市場調査レポート

神経機能代替術の世界市場(製品種・技術・用途・地域別) - 市場規模、シェア、世界動向、企業プロファイル、需要、考察、分析、調査、レポート、機会、セグメンテーションおよび予測

Global Neuroprosthetics Market (Product Types, Technology, Application, and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

発行 Allied Market Research 商品コード 320778
出版日 ページ情報 英文 156 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。
Back to Top
神経機能代替術の世界市場(製品種・技術・用途・地域別) - 市場規模、シェア、世界動向、企業プロファイル、需要、考察、分析、調査、レポート、機会、セグメンテーションおよび予測 Global Neuroprosthetics Market (Product Types, Technology, Application, and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020
出版日: 2014年11月14日 ページ情報: 英文 156 Pages
概要

神経機能代替術は、神経・脳インプラントともいわれ、従来の治療法では不可能とされてきた損傷後の感覚・運動・認知機能の復元に対する有望性から、過去数年にわたって大幅に勢いを増しています。患者の「生活の質」を回復・向上するための要となる同技術の研究開発には、官民各方面から投資が集まり、その世界市場は今後数年にわたって15.8%の複合年間成長率で発展し、2020年には140億ドル規模に達する見込みです。

当レポートでは、神経機能代替の世界市場に注目し、取引規模の推移を製品種、技術、用途、地域の別に分析・予測するほか、市場発展の推進・抑制要因、研究開発、競合環境、主要参入企業などについての最新情報を集めています。

第1章 イントロダクション

  • レポート内容
  • レポートの主要利点
  • 主要市場セグメント
  • レポートの推奨利用者層
  • 調査方法
    • 二次情報調査
    • 一次情報取材
    • 分析ツールおよびモデル

第2章 エグゼクティブサマリー

  • 市場予測(単位:100万ドル)
    • 堅実成長シナリオ
    • 急成長シナリオ
    • 減速成長シナリオ

第3章 市場概要

  • 市場の定義と範囲
  • 上限で見た市場展開
  • 倫理的考察
  • 重要所見
    • 神経機能代替技術への主要影響ファクター
    • 有力資金源
    • 成功への重要戦略
  • 神経移植発展史
    • 定位固定移植
      • 歴史的視点
      • 現在の動向
      • 競合状況
    • 電気生理マッピング
      • 歴史的視点
      • 現在の動向
      • 競合状況
  • 行政府規制
    • 米国の医療機器規定
    • 欧州の医療機器規定
    • アジア太平洋地域の医療機器規定
    • 各地域における規制当局承認の時間的枠組み
  • 特許分析
    • 地域別特許分析
    • 疾患状況別特許分析
  • 神経機能代替の治験
  • バリューチェーン分析
    • 脳機械インターフェースと神経刺激装置
    • 組込み人工神経装置・インプラント
  • 市場シェア分析
  • 市場動態
    • 推進要因
      • 技術の急発展 - 神経機能代替技術向上に貢献
      • 新鋭機器の認可 - 早期商業化で競争力確立へ
      • 神経刺激治療の対象となる神経疾患の重圧
      • 資金および研究助成金の存在
    • 抑制要因
      • 報酬問題 - 神経機能代替術普及率に与えるマイナス影響
      • 副作用 - 致死リスクを増大させ、利用率低下を招く要因
      • 高額な製品や治療の費用
    • 機会
      • 開発段階にある製品の早期商業化で競争力増大へ

第4章 神経機能代替術の世界市場 - 技術別(単位:100万ドル)

  • 脳深部刺激法(DBS)
    • 歴史的視点
    • 現在の動向
    • 競合状況
  • 迷走神経刺激法(VNS)
  • 脊髄電気刺激法(SCS)
  • 仙骨神経(SNS)

第5章 神経機能代替術の世界市場 - 形態別(単位:100万ドル)

  • 運動補綴
  • 聴覚補綴・人工内耳
  • 視覚補綴・網膜移植
  • 知覚補綴

第6章 神経機能代替術の世界市場 - 用途別(単位:100万ドル)

  • 運動神経障害
    • パーキンソン病
    • てんかん
  • 生理障害
    • 聴覚障害
    • 眼科障害
    • 心臓障害
    • 腎臓障害
  • 認知障害
    • アルツハイマー病
    • 憂鬱症

第7章 神経機能代替術の世界市場 - 地域別(単位:100万ドル)

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他の地域

第8章 企業プロファイル(企業概要、寸評、事業セグメント、収益、戦略的動きおよび展開、SWOT分析)

  • Boston Scientific Corporation
  • Cochlear Limited
  • Cyberonics Inc.
  • Medtronic Inc.
  • NDI Medical LLC
  • Nervo Corp.
  • NeuroPace Inc.
  • Retina Implant AG
  • ST. Jude Medical
  • Sonova Group (Advanced Bionics AG)
目次
Product Code: ME 14580

Neuroprosthetics, also referred to as neural implants/brain implants, have gained significant momentum during past few years owing to the immense potential to substitute and/or ameliorate any damaged sensory, motor or cognitive functions. Such Neuroprosthetics are the key to restore and/or augment the 'quality-of-life' of the affected patient populace. The Neuroprosthetics, as therapeutic modalities, are emerging as a promising option in cases where all conventional treatments fail to deliver results/treatment to the disease condition. Improvement in the 'quality-of-life' of the affected patients, high availability of funds for R&D of Neuroprosthetics from the Government (public) and private sector investments in turn aid development of newer and improved variants of Neuroprosthetics - all result in increased uptake by the patients. Thus, the afore-mentioned are key drivers of the Neuroprosthetics market; however, reimbursement issues and high cost of Neuroprosthetics/devices are the restraints to the market growth. Owing to the high-impact growth drivers that outweigh the restraints, the global neuroprosthetics market is forecast to reach $14 billion by 2020, registering a CAGR of 15.8% from 2014 to 2020.

The global neuroprosthetics market is segmented based on technology, types, applications and geography. The Neuroprosthetics' Mechanism Of Action (MOA) varies as per underlying technology; hence, Neuroprosthetics can also be classified by technology into - Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Spinal Cord Stimulation (SCS) and Sacral Nerve Stimulation (SCS). Various types of Neuroprosthetics have been developed based on the application areas, i.e., the disease condition treated, for example, Motor Neuroprosthetics - treat motor neuron disorders such as Parkinson's disease, Epilepsy, Auditory Neuroprosthetics/ Cochlear implants - treat hearing disorders; Visual Neuroprosthetics/ Retinal implants - treat visual impairment; and Cognitive Neuroprosthetics - treat Alzheimer's disease, and severe depression. Visual Neuroprosthetics/ Retinal implants, is the fastest growing (CAGR 31.5%) Neuroprosthetics segment, owing to high-impact growth attribute of improving 'quality-of-life' of visually impaired patients. Geographically, the market is segmented into four regions, namely North America, Europe, Asia-Pacific and LAMEA.

Developing bio-compatible, sensitive and safe products are the keys to success in the global Neuroprosthetics market. In tune with this, many companies across the world are involved in the R&D of newer and multitude of variants of Neuroprosthetics' product lines and is seeking regulatory approval and commercialization. Few of such companies are profiled in the report - Medtronic Inc., MED-EL, Advanced Bionics AG, Boston Scientific Corporation, Biomet, Inc., St. Jude Medical, Retina Implant AG, NeuroPace, Inc. and NDI Medical LLC.

KEY BENEFITS

  • An in-depth analysis of the current Neuroprosthetics market scenario, future market estimates and trend-analysis - to reveal holistic picture that in turn facilitates decision making
  • Quantitative analysis of the current market and estimations through 2013-2020 - to assist corporate strategists to design business strategies to capitalize on the current and future (possible) opportunities in the market
  • Strategic analysis of key market players and business strategies within the global Neuroprosthetics market provided - would assist stakeholders to make informed business decisions
  • Pinpoint intelligence of key investment pockets are illustrated from the manufacturers point of view
  • Report emphasizes on the key strategies adopted by the giants operating in the neuroprosthetic devices market
  • Technological trends of neurological devices are critically analyzed and validated through primaries
  • Identification of key product segments based on current and potential growth prospects - to reveal most profitable segments that can be catered to by the market players

MARKET SEGMENTATION

The global neuroprosthetics market is segmented according to / by - technology, type, application, and geography.

MARKET BY TECHNOLOGY

  • Deep Brain Simulation (DBS)
  • Vagus Nerve Stimulation (VNS)
  • Spinal Cord Stimulation (SCS)
  • Sacral Nerve Stimulation (SNS)

MARKET BY TYPE

  • Motor Neuroprosthetics
  • Auditory Neuroprosthetics/ Cochlear implants
  • Visual Neuroprosthetics/ Retinal implants
  • Cognitive Neuroprosthetics

MARKET BY APPLICATION

  • Motor Neuron disorders
  • Parkinson's disease
  • Epilepsy
  • Physiological disorders
  • Auditory disorders
  • Ophthalmic disorders
  • Neurocardiac disorders
  • Over Active Bladder syndrome (kidney disorders)
  • Cognitive disorders
  • Alzheimer's disease
  • Severe depression

MARKET BY GEOGRAPHY

  • North America
  • Europe
  • Asia-Pacific
  • LAMEA

Table of Contents

CHAPTER 1 INTRODUCTION

  • 1.1 Report Description
  • 1.2 Key Benefits
  • 1.3 Key Market Segments
  • 1.4 Key Audiences
  • 1.5 Research Methodology
    • 1.5.1 Primary Research
    • 1.5.2 Secondary Research
    • 1.5.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

  • 2.1 Market beyond what to expect by 2025 ($Million)
    • 2.1.1 Moderate growth scenario
    • 2.1.2 Rapid growth scenario
    • 2.1.3 Diminishing growth scenario

CHAPTER 3 MARKET OVERVIEW

  • 3.1 Market Definition and Scope
  • 3.2 Addressable Market Scenario
  • 3.3 Ethical Considerations
  • 3.4 Key Findings
    • 3.4.1 Top Factors Impacting on global neuroprosthetics market
    • 3.4.2 Top Investment Pockets of global neuroprosthetics market
    • 3.4.3 Top winning strategies of global neuroprosthetics market
  • 3.5 Advances in neuroprosthetic implantation
    • 3.5.1 Stereotactic implantation
      • 3.5.1.1 Historical Perspective
      • 3.5.1.2 Current Trends
        • 3.5.1.2.1 INCREASING USE OF MRI, CT SCANS AND OTHER IMAGE GUIDING SYSTEMS FOR STEREOTACTIC IMPLANTATION
        • 3.5.1.2.2 ROBOTS FOR IMPROVED STEREOTAXIC PRECISION
      • 3.5.1.3 Competitive scenario
    • 3.5.2 Electrophysiological mapping
      • 3.5.2.1 Historical Perspective
      • 3.5.2.2 Current Trends
        • 3.5.2.2.1 EVOKED POTENTIAL MONITORING
        • 3.5.2.2.2 SINGLE-UNIT RECORDINGS
      • 3.5.2.3 Competitive scenario
  • 3.6 Government Regulations
    • 3.6.1 Medical Devices regulations in United States (U.S.)
    • 3.6.2 Medical Devices regulations in Europe and UK
    • 3.6.3 Medical Devices regulations in Asia-Pacific
    • 3.6.4 Regulatory approval timeframe in different regions
  • 3.7 Patent Analysis
    • 3.7.1 Patent analysis by geographies (2010-2014)
    • 3.7.2 Patent analysis based on medical condition (2011-2014)
  • 3.8 Clinical Trials for Neuroprosthetics
  • 3.9 Value chain analysis
    • 3.9.1 Brain Machine interfaces and neurostimulators
    • 3.9.2 Embedded neuroprosthetic devices/implants
  • 3.10 Market Share Analysis
  • 3.11 Market Dynamics
    • 3.11.1 Drivers
      • 3.11.1.1 Rapid progression of technology - assist in improving neuroprosthetics
      • 3.11.1.2 New device approvals- leading towards early commercialization to achieve competitive edge
      • 3.11.1.3 Rising burden of neurological disorders that responds to neurostimulation
      • 3.11.1.4 Availability of Funds and research grants
    • 3.11.2 Restraints
      • 3.11.2.1 Reimbursement Issues - have negative impact on neuroprosthetics adoption rate
      • 3.11.2.2 Adverse reactions- increases risk of mortality and decreases usage rate
      • 3.11.2.3 High cost of product and therapy
    • 3.11.3 Opportunities
      • 3.11.3.1 Early commercialization of pipeline products assists to gain competitive advantage

CHAPTER 4 GLOBAL NEUROPROSTHETICS MARKET BY TECHNOLOGY, 2013-2020, $MILLION

  • 4.1 Deep Brain Simulation (DBS)
    • 4.1.1 Historical Perspective
    • 4.1.2 Current Trends
      • 4.1.2.1 Advancement in component system
      • 4.1.2.2 Other technological advances
    • 4.1.3 Competitive Scenario
  • 4.2 Vagus Nerve Stimulation (VNS)
    • 4.2.1 Historical Perspective
    • 4.2.2 Current trends
      • 4.2.2.1 Direct and transcutaneous vagus nerve stimulators are gaining popularity
    • 4.2.3 Competitive Scenario
  • 4.3 Spinal Cord Stimulation (SCS)
    • 4.3.1 Historical Perspective
    • 4.3.2 Current trends
      • 4.3.2.1 Rechargeable neurostimulation system gaining significant attention
        • 4.3.2.1.1 RESTORE™ RECHARGEABLE NEUROSTIMULATION SYSTEM
        • 4.3.2.1.2 EON™ NEUROSTIMULATION SYSTEM
        • 4.3.2.1.3 PRECISION™ SPINAL CORD STIMULATION SYSTEM
    • 4.3.3 Competitive Scenario
  • 4.4 Sacral Nerve Stimulation (SNS)
    • 4.4.1 Historical Perspective
    • 4.4.2 Current trends

CHAPTER 5 GLOBAL NEUROPROSTHETICS MARKET BY TYPE, 2013-2020, $MILLION

  • 5.1 Motor Prosthetics
    • 5.1.1 Key Market Trends
    • 5.1.2 Key growth factors and opportunities
    • 5.1.3 Market Size and forecast
  • 5.2 Auditory Prosthetics / Cochlear Implants
    • 5.2.1 Key Market Trends
    • 5.2.2 Key growth factors and opportunities
    • 5.2.3 Market Size and forecast
  • 5.3 Visual Prosthetics / Retinal Implants
    • 5.3.1 Key Market Trends
    • 5.3.2 Key growth factors and opportunities
    • 5.3.3 Market Size and forecast
  • 5.4 Cognitive Prosthetics
    • 5.4.1 Key Market Trends
    • 5.4.2 Key growth factors and opportunities
    • 5.4.3 Market Size and forecast

CHAPTER 6 GLOBAL NEUROPROSTHETICS MARKET BY APPLICATION, 2013-2020, $MILLION

  • 6.1 Motor Neuron disorders
    • 6.1.1 Parkinson's disease
    • 6.1.2 Epilepsy
  • 6.2 Physiological disorders
    • 6.2.1 Auditory disorders
    • 6.2.2 Ophthalmic disorders
    • 6.2.3 Cardiac disorders
    • 6.2.4 Kidney disorders
  • 6.3 Cognitive disorders
    • 6.3.1 Alzheimer's disease
    • 6.3.2 Severe depression

CHAPTER 7 GLOBAL NEUROPROSTHETICS MARKET BY GEOGRAPHY, 2013-2020, $MILLION

  • 7.1 North America
    • 7.1.1 Key market trends
    • 7.1.2 Competitive scenario
    • 7.1.3 Key growth factors and opportunities
    • 7.1.4 Market size and forecast
  • 7.2 Europe
    • 7.2.1 Key market trends
    • 7.2.2 Competitive scenario
    • 7.2.3 Key growth factors and opportunities
    • 7.2.4 Market size and forecast
  • 7.3 Asia-Pacific
    • 7.3.1 Key market trends
    • 7.3.2 Competitive scenario
    • 7.3.3 Key growth factors and opportunities
    • 7.3.4 Market size and forecast
  • 7.4 LAMEA
    • 7.4.1 Key market trends
    • 7.4.2 Competitive scenario
    • 7.4.3 Key growth factors and opportunities
    • 7.4.4 Market size and forecast

CHAPTER 8 COMPANY PROFILES

  • 8.1 Boston Scientific Corporation
    • 8.1.1 Overview
    • 8.1.2 Company snapshot
    • 8.1.3 Operating Business Segments
    • 8.1.4 Financial performance
    • 8.1.5 Strategic moves and developments
    • 8.1.6 SWOT analysis
  • 8.2 Cochlear Limited
    • 8.2.1 Overview
    • 8.2.2 Company snapshots
    • 8.2.3 Operating Business Segments
    • 8.2.4 Financial performance
    • 8.2.5 Strategic moves and developments
    • 8.2.6 SWOT analysis
  • 8.3 Cyberonics Inc.
    • 8.3.1 Overview
    • 8.3.2 Company snapshot
    • 8.3.3 Operating Business Segments
    • 8.3.4 Financial performance
    • 8.3.5 Strategic moves and developments
    • 8.3.6 SWOT analysis
  • 8.4 Medtronic Inc.
    • 8.4.1 Company overview
    • 8.4.2 Company snapshots
    • 8.4.3 Operating Business Segments
    • 8.4.1 Financial performance
    • 8.4.2 Strategic moves and developments
    • 8.4.3 SWOT Analysis
  • 8.5 NDI Medical LLC
    • 8.5.1 Overview
    • 8.5.2 Company snapshot
    • 8.5.3 Operating Business Segments
    • 8.5.4 Strategic moves and developments
    • 8.5.5 SWOT analysis
  • 8.6 Nervo Corp.
    • 8.6.1 Overview
    • 8.6.2 Company snapshot
    • 8.6.3 Operating Business Segments
    • 8.6.4 Strategic moves and developments
    • 8.6.5 SWOT analysis
  • 8.7 NeuroPace Inc.
    • 8.7.1 Overview
    • 8.7.2 Company snapshot
    • 8.7.3 Operating Business Segments
    • 8.7.4 Strategic moves and developments
    • 8.7.5 SWOT analysis
  • 8.8 Retina Implant AG
    • 8.8.1 Overview
    • 8.8.2 Company snapshot
    • 8.8.3 Operating Business Segments
    • 8.8.4 Strategic moves and developments
    • 8.8.5 SWOT analysis
  • 8.9 ST. Jude Medical
    • 8.9.1 Overview
    • 8.9.2 Company snapshot
    • 8.9.3 Operating Business Segments
    • 8.9.4 Financial performance
    • 8.9.5 Strategic moves and developments
    • 8.9.6 SWOT analysis
  • 8.10 Sonova Group (Advanced Bionics AG)
    • 8.10.1 Company overview
    • 8.10.2 Company snapshots
    • 8.10.3 Operating Business Segments
    • 8.10.4 Financial performance
    • 8.10.5 Strategic moves and developments
    • 8.10.6 SWOT analysis

List of Tables

  • TABLE 1 MODERATE GROWTH SCENARIO OF NEUROPROSTHETICS MARKET BY GEOGRAPHY, 2020 - 2025, ($MILLION)
  • TABLE 2 RAPID GROWTH SCENARIO OF NEUROPROSTHETICS MARKET BY GEOGRAPHY, 2020 - 2025, ($MILLION)
  • TABLE 3 DIMINISHING GROWTH SCENARIO OF NEUROPROSTHETICS MARKET BY GEOGRAPHY, 2020 - 2025, ($MILLION)
  • TABLE 4 MEDICAL DEVICE CATEGORIES LISTED BY EC
  • TABLE 1 PATENT ANALYSIS BY GEOGRAPHIES (2011-2014)
  • TABLE 2 CLINICAL TRIALS FOR NEUROPROSTHETICS
  • TABLE 3 CURRENT RESEARCH IN EMERGING TECHNOLOGIES AND THEIR APPLICATIONS IN NEUROPROSTHETICS
  • TABLE 4 LIST OF USFDA APPROVED, COMMERCIALLY AVAILABLE NEUROPROSTHETICS
  • TABLE 5 GLOBAL PREVALENCE OF NEUROLOGICAL DISORDERS
  • TABLE 6 AVERAGE COST OF NEUROPROSTHETIC THERAPY/ PRODUCTS
  • TABLE 7 GLOBAL NEUROPROSTHETICS MARKET BY TECHNOLOGY, 2013 - 2020 ($MILLION)
  • TABLE 8 FDA APPROVED APPLICATIONS FOR DEEP BRAIN STIMULATION
  • TABLE 9 VAGUS NERVE STIMULATION DEVICE: FACT SHEET
  • TABLE 10 GLOBAL NEUROPROSTHETICS MARKET BY TYPES, 2013 - 2020 ($MILLION)
  • TABLE 11 COMPANIES AND THEIR FDA APPROVED COCHLEAR IMPLANTS
  • TABLE 12 GLOBAL NEUROPROSTHETICS MARKET BY APPLICATION, 2013 - 2020 ($MILLION)
  • TABLE 13 PARKINSON'S DISEASE NEUROPROSTHETICS MARKET, 2013 - 2020 ($MILLION)
  • TABLE 14 EPILEPSY NEUROPROSTHETICS MARKET, 2013 - 2020 ($MILLION)
  • TABLE 15 GLOBAL ESTIMATE AND PREVALENCE OF DISABLING HEARING LOSS, IN ADULTS 15 YEARS OR OLDER AND CHILDREN 0-14 YEARS (MILLIONS AND PERCENTAGE OF POPULATION)
  • TABLE 16 AUDITORY DISORDERS NEUROPROSTHETICS MARKET, 2013 - 2020 ($MILLION)
  • TABLE 17 OPHTHALMIC DISORDERS NEUROPROSTHETICS MARKET, 2013 - 2020 ($MILLION)
  • TABLE 18 NEUROCARDIAC DISORDERS NEUROPROSTHETICS MARKET, 2013 - 2020 ($MILLION)
  • TABLE 19 KIDNEY DISORDERS NEUROPROSTHETICS MARKET, 2013 - 2020 ($MILLION)
  • TABLE 20 ALZHEIMEER'S DISEASE NEUROPROSTHETICS MARKET, 2013 - 2020 ($MILLION)
  • TABLE 21 SEVERE DEPRESSION NEUROPROSTHETICS MARKET, 2013 - 2020 ($MILLION)
  • TABLE 22 GLOBAL NEUROPROSTHETICS MARKET BY GEOGRAPHY, 2013 - 2020 ($MILLION)
  • TABLE 23 NORTH AMERICA NEUROPROSTHETICS MARKET BY VALUE, 2013 - 2020 ($MILLION)
  • TABLE 24 EUROPE NEUROPROSTHETICS MARKET BY VALUE, 2013 - 2020 ($MILLION)
  • TABLE 25 ASIA-PACIFIC NEUROPROSTHETICS MARKET BY VALUE, 2013 - 2020 ($MILLION)
  • TABLE 26 LAMEA NEUROPROSTHETICS MARKET BY VALUE, 2013 - 2020 ($MILLION)
  • TABLE 27 BOSTON SCIENTIFIC CORPORATION SNAPSHOT
  • TABLE 28 BOSTON SCIENTIFIC CORPORATION OPERATING SEGMENTS
  • TABLE 29 COCHLEAR CORPORATION SNAPSHOT
  • TABLE 30 COCHLEAR CORPORATION OPERATING SEGMENTS
  • TABLE 31 CYBERONICS INC SNAPSHOT
  • TABLE 32 MEDTRONIC SNAPSHOT
  • TABLE 33 MEDTRONIC OPERATING SEGMENTS
  • TABLE 34 NDI MEDICAL SNAPSHOT
  • TABLE 35 NDI MEDICAL LLC OPERATING SEGMENTS
  • TABLE 36 NERVO CORP. SNAPSHOT
  • TABLE 37 NEUROPACE INC. SNAPSHOT
  • TABLE 38 RETINA IMPLANT AG SNAPSHOT
  • TABLE 39 ST. JUDE MEDICAL SNAPSHOT
  • TABLE 40 ST. JUDE MEDICAL OPERATING SEGMENTS
  • TABLE 41 SONOVA GROUP SNAPSHOT
  • TABLE 42 SONOVA GROUP OPERATING SEGMENTS

List of Figures

1 TOP FACTORS IMPACTING NEUROPROSTHETICS MARKET (2013-2020)

  • FIG. 2 TOP INVESTMENT POCKETS OF GLOBAL NEUROPROSTHETICS MARKET(2013)
  • FIG. 3 TOP WINING STRATEGIES FOR GLOBAL NEUROPROSTHETICS MARKET (2011-2014)
  • FIG. 4 STRATEGIC SHARE OF NEUROPROSTHETICS APPLICATION
  • FIG. 5 TOP WINING STRATEGIES BY NEUROPROSTHETICS APPLICATION
  • FIG. 6 FDA APPROVED INDICATIONS FOR NEUROPROSTHETICS
  • FIG. 7 AVERAGE APPROVAL TIME FOR DIFFERENT CLASSES OF MEDICAL DEVICE IN LEADING MARKETS IN 2013
  • FIG. 8 PATENT ANALYSIS BY GEOGRAPHIES (2011-2014)
  • FIG. 9 PATENT ANALYSIS BASED ON MEDICAL CONDITION(2011-2014)
  • FIG. 10 NEUROPROSTHETICS- VALUE CHAIN
  • FIG. 11 GLOBAL NEUROPROSTHETICS MARKET SHARE ANALYSIS (2013)
  • FIG. 12 GLOBAL MOTOR PROSTHETICS MARKET, 2013 - 2020 ($MILLION)
  • FIG. 13 GLOBAL AUDITORY PROSTHETICS MARKET, 2013 - 2020 ($MILLION)
  • FIG. 14 GLOBAL VISUAL PROSTHETICS MARKET, 2013 - 2020 ($MILLION)
  • FIG. 15 GLOBAL COGNITIVE PROSTHETICS MARKET, 2013 - 2020 ($MILLION)
  • FIG. 16 PREVALENCE OF ALZHEIMER'S DISEASE IN UNITED STATES, BY AGE (2014)
  • FIG. 17 REVENUE OF BOSTON SCIENTIFIC CORPORATION. BY GEOGRAPHY(2013)
  • FIG. 18 REVENUE BOSTON SCIENTIFIC CORPORATION. BY PRODUCT GROUPS(2013)
  • FIG. 19 SWOT ANALYSIS OF BOSTON SCIENTIFIC CORPORATION.
  • FIG. 20 REVENUE OF COCHLEAR CORPORATION LTD. BY GEOGRAPHY(2014)
  • FIG. 21 REVENUE OF COCHLEAR CORPORATION LTD. BY PRODUCT GROUPS(2014)
  • FIG. 22 SWOT ANALYSIS OF MEDTRONIC INC.
  • FIG. 23 REVENUE OF CYBERONICS INC. BY GEOGRAPHY(2014)
  • FIG. 24 SWOT ANALYSIS OF CYBERONICS INC.
  • FIG. 25 REVENUE OF MEDTRONIC INC. BY GEOGRAPHY(2013)
  • FIG. 26 REVENUE MEDTRONIC INC. BY BUSINESS GROUP(2013)
  • FIG. 27 SWOT ANALYSIS OF MEDTRONIC INC.
  • FIG. 28 SWOT ANALYSIS OF NDI MEDICAL LLC.
  • FIG. 29 SWOT ANALYSIS OF NERVO CORP.
  • FIG. 30 SWOT ANALYSIS OF NEUROPACE INC.
  • FIG. 31 SWOT ANALYSIS OF NEUROPACE INC.
  • FIG. 32 NET SALES OF ST. JUDE MEDICAL. BY GEOGRAPHY(2013)
  • FIG. 33 NET SALES OF ST. JUDE MEDICAL. BY BUSINESS GROUP(2013)
  • FIG. 34 SWOT ANALYSIS OF ST. JUDE MEDICAL.
  • FIG. 35 REVENUE OF SONOVA GROUP. BY GEOGRAPHY(2013/14)
  • FIG. 36 REVENUE SONOVA GROUP. BY PRODUCT GROUPS(2013/14)
  • FIG. 37 SWOT ANALYSIS OF SONOVA HOLDING AG.
Back to Top